Phenicol

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Phenicol

Quick Facts

Property Description
Active Ingredient Chloramphenicol
Form Oral capsules, injectable solution, ophthalmic preparations
Pharmacological Class Broad-Spectrum Antibiotic / Antimicrobial Agent
General Purpose Halting bacterial growth and multiplication
Origin Synthetic

What Type of Medicine is Phenicol (Chloramphenicol)?

Phenicol is an established medicine containing the active ingredient Chloramphenicol, which is classified as a broad-spectrum antibiotic and a versatile antimicrobial agent. This medicine is recognized for its role in global health and is primarily used to address issues stemming from a wide range of susceptible bacterial microorganisms. The compound is synthetic, meaning it is chemically manufactured rather than being directly sourced from nature, though its structure was originally inspired by the bacterium Streptomyces venezuelae. Its distinctive pharmacological profile supports its clinical utility across varied infection types.


How is Phenicol Classified and Formulated?

The core function of Phenicol is to act as a bacteriostatic agent by operating as a protein synthesis inhibitor within bacterial cells. The mechanism involves physically binding to the bacterial 50S ribosomal subunit, which prevents the necessary formation of proteins required for bacterial multiplication. This action defines the drug's role in stopping the bacteria's growth machinery. Chloramphenicol is notable for its versatility, as it is manufactured in diverse pharmaceutical preparations, including oral capsules and injectable solution for systemic use, as well as specialized ophthalmic preparations for topical treatment. While the drug is predominantly a single-active-ingredient product, some manufacturers also produce combination topical forms, such as those that might include an anti-inflammatory component alongside the Chloramphenicol.


What is the General Purpose of This Antibiotic?

The general purpose of this broad-spectrum antibiotic is to intervene against microbial populations by halting their ability to grow and reproduce. By functioning as a bacteriostatic agent, Phenicol prevents the increase of bacterial overgrowth, allowing the body’s own defense mechanisms to better manage the underlying condition. For instance, the ophthalmic preparations are typically used when a bacterial proliferation occurs on the surface of the eye. This fundamental goal provides a level of control in situations where susceptible microbes are multiplying, thereby supporting the natural resolution of the infection.

Regulatory References

  1. World Health Organization Model List of Essential Medicines

What side effects are possible with Phenicol?

Possible Side Effects and Safety Information


Phenicol antibiotics, such as Chloramphenicol, carry a risk of serious and potentially fatal side effects, primarily affecting the blood and bone marrow. Due to these risks, its systemic use (oral or intravenous) is generally reserved for severe infections where safer alternatives are ineffective or contraindicated.

Serious Adverse Effects

  • Aplastic Anemia: This is a rare, idiosyncratic, and often fatal reaction where the bone marrow fails to produce sufficient blood cells. This effect is not dose-related and can occur weeks or months after treatment has been stopped.
  • Dose-Related Bone Marrow Suppression: This is a more common, predictable, and usually reversible effect that manifests as a fall in hemoglobin and a decrease in red and white blood cells and platelets. It is directly related to the dose and duration of therapy and typically resolves once the drug is discontinued. Regular blood monitoring (complete blood counts) is crucial during treatment to detect this early.
  • Gray Baby Syndrome: A life-threatening condition in newborn and premature infants. It occurs because their livers are too immature to efficiently metabolize the drug, leading to toxic accumulation. Symptoms include abdominal distension, vomiting, cyanosis (gray skin color), labored breathing, and cardiovascular collapse. This makes its use in neonates, late pregnancy, and breastfeeding generally contraindicated.

Common and Less Severe Effects

Common side effects often involve the gastrointestinal tract, including nausea, vomiting, diarrhea, and mouth soreness. Neurological effects such as headache, confusion, or depression may also occur. Prolonged use, especially with eye drops or systemic forms, has been associated with optic and peripheral neuritis (damage to the nerves, which may cause vision changes or numbness/tingling). If these symptoms occur, the drug should typically be withdrawn promptly.

Important Safety Precautions

Patients should inform their healthcare provider of any history of liver or kidney disease, bone marrow disorders, or previous treatment with Phenicol. Due to potential drug interactions and the risk of severe blood problems, comprehensive patient history and ongoing monitoring are essential for safe use.

Overdose and Emergency Response

Phenicol Overdose and when to seek help

Overdose with Phenicol (Chloramphenicol) is an officially documented serious risk that necessitates immediate medical intervention due to potential life-threatening outcomes. Regulatory authorities mandate that individuals seek immediate medical attention and contact emergency services immediately upon any suspicion of overdose.


Documented Overdose Presentations

Presentation Type Regulatory Findings
Clinical Manifestations Nausea, vomiting, diarrhea, pallor, hypotension, and shock. In infants, the Gray Baby Syndrome presents with progressive cyanosis, irregular respiration, and systemic collapse.
Severe Outcomes The risk of developing Irreversible Aplastic Anemia and severe cardiovascular collapse are officially documented outcomes.

Required Emergency Management

Management Focus Official Statement in Labeling
Antidote Status No specific antidote is known.
Required Action Management is primarily symptomatic and supportive. Procedures to enhance drug elimination, such as hemoperfusion or exchange transfusion, may be necessary.
Monitoring Close and continuous hematological monitoring and observation in a hospital setting are required due to the risk of severe bone marrow depression.

The official overdose profile is defined by the severity of these outcomes, particularly the systemic toxicity and hematological injury. Urgent medical care is required for all suspected overdose scenarios, especially in neonates and patients with known hepatic or renal impairment, who are noted to be at a heightened risk of toxicity.

Therapeutic Uses of Phenicol

What Phenicol Treats: Main Uses and Benefits

Phenicol is a medicine commonly applied when symptoms are caused by certain susceptible bacteria and when supportive symptom management is appropriate.

Therapeutic Domains

Phenicol is used in the management of serious and potentially life-threatening systemic bacterial infections—such as Typhoid fever and specific types of bacterial Meningitis—and is relevant for managing acute, localized bacterial infections of the eye's surface, including bacterial conjunctivitis. In acute clinical contexts, it may assist with managing severe symptoms related to systemic imbalance. It contributes to control over bacterial growth, which helps with stabilizing the patient, easing persistent high fever, and supports the patient during difficult episodes associated with critical illness. It is also relevant for easing symptoms linked to functional stress, particularly those pathogens associated with Rickettsial diseases or multidrug resistance.

In topical applications, it offers the patient support that helps ease acute symptoms, addressing visible discomfort, inflammation, and eye redness that interfere with daily functioning.


Quick Fact: Support for Acute Systemic and Ocular Symptoms
Primary Focus Severe Systemic Infections and Acute Bacterial Eye Infections
Symptom Eased Persistent fever, systemic distress, eye redness, and discomfort
Context of Use Reserved for life-threatening conditions or in situations requiring additional symptomatic assistance

Regulatory References

  1. NIH StatPearls Chloramphenicol Overview

Eligibility and Restrictions for Use

The systemic use of Phenicol (Chloramphenicol) is officially restricted, generally reserved for patients requiring treatment for serious, life-threatening infections where other less hazardous agents are either ineffective or contraindicated.

Populations Strictly Contraindicated (Must Not Use)

Regulatory labeling enforces strict exclusions:

  • Individuals with a known history of hypersensitivity or a prior toxic reaction to Chloramphenicol.
  • Patients with pre-existing bone marrow disease or conditions like aplastic anemia or other blood dyscrasias.
  • Patients diagnosed with acute porphyria.
  • The medicine is explicitly prohibited for treating trivial infections (such as the common cold) or for preventative (prophylactic) purposes.

Populations Requiring Conditional Use

Use in these groups is permitted only with heightened caution and supervision:

  • Neonates and Infants: Use is severely restricted in infants, especially those under two weeks of age, due to the risk of "Gray Syndrome," demanding rigorous blood concentration monitoring.
  • Organ Impairment: Patients with impaired liver or renal function require mandatory dose adjustment and close supervision due to the potential for drug accumulation.
  • Pregnancy/Lactation: Use is generally not recommended during the last stages of pregnancy and while breastfeeding due to the documented risk of infant toxicity.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Phenicol (Chloramphenicol) primarily addresses the critical constraints required to prevent the risk of severe, additive adverse effects and altered drug exposures.

Interaction Type Interacting Substance/Class Regulatory Constraint and Consequence
Additive Toxicity Medicines liable to depress bone marrow function (e.g., Azathioprine, Cyclophosphamide) Co-administration should be avoided due to the significantly increased and serious risk of bone marrow depression (e.g., aplastic anemia).
Pharmacodynamic Antagonism Bacteriostatic antibiotics Co-administration should not be combined as stated in official labeling.
Pharmacokinetic Inhibition Certain Cytochrome P450 (CYP) Substrates (e.g., Phenytoin, Fosphenytoin, Tacrolimus) Phenicol may inhibit the metabolism of these co-administered drugs, leading to increased plasma levels and potential toxicity of the interacting medicine.

Systemic absorption may occur following topical administration (e.g., eye or ear preparations), meaning that potential drug interactions are a relevant consideration even with non-oral use. The interaction profile necessitates that healthcare providers review concurrent medications, including other antibiotics and immunosuppressants, before prescribing to manage the officially documented risks.

Mechanism of Action

Targeting the Bacterial Protein Synthesis Machinery

This domain describes how Phenicol works by focusing on its primary target, the bacterial 50S ribosomal subunit. By binding to this subunit , the drug initiates a precise molecular block that prevents the construction of new proteins, which is required for the target cell's proliferation.


Interference in Peptide Bond Formation

This mechanistic cascade details the subsequent step: the inhibition of the peptidyl transferase enzyme. This action immediately halts the formation of peptide bonds, which are the chemical linkages that connect amino acids to form a polypeptide. This targeted molecular interference results in the physiological consequence of inhibiting microbial proliferation, consistent with the mechanism of a bacteriostatic agent.

Dosage and Administration Information

Administration Methods

Phenicol is available in several formulations, including oral capsules and topical preparations such as ophthalmic or otic solutions. The method of administration depends entirely on the specific form prescribed and the nature of the condition being addressed.

Oral Administration

When taken orally, the medication is typically swallowed with a full glass of water. It is generally recommended to maintain a consistent schedule to ensure steady levels of the substance remain in the system throughout the duration of use. Absorption can be affected by the presence of food, though requirements vary based on individual tolerance.

Ophthalmic and Otic Application

For localized applications, such as in the eye or ear, the following general principles apply:

  • Ophthalmic (Eye): Solutions or ointments are applied directly to the affected eye. Cleanliness of the applicator tip is maintained by avoiding contact with any surface, including the eye itself, to prevent contamination of the product.
  • Otic (Ear): Drops are instilled into the ear canal. It is often suggested to remain in a stationary position for a short period following application to allow the medication to reach the affected area.

Consistency and Duration

The effectiveness of the application process relies on following the designated timeframe provided during the initial consultation. Even if symptoms appear to resolve early, the process is typically continued until the supply is exhausted to ensure the intended outcome is fully realized. If a scheduled application is missed, the routine is usually resumed at the next planned interval rather than doubling the amount used.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Phenicol

Evidence for use in Systemic Bacterial Infections (Typhoid Fever, Meningitis)

Phenicol was studied for severe systemic conditions like Typhoid fever and bacterial Meningitis using a mix of early clinical trials and systematic reviews. The research examined outcomes related to physiological strain and physical discomfort, such as monitoring fever clearance time, clinical cure rates, and patient survival patterns. Early studies reported observed changes during the acute treatment period. However, a key limitation is the reliance on older trials conducted before the widespread emergence of antimicrobial resistance, which means certainty is low regarding the current applicability of all findings. Data regarding long-term outcomes remain limited.


Evidence for use in Acute Bacterial Eye Infections (Ocular Applications)

Research exploring short-term symptom changes in acute bacterial conjunctivitis primarily consists of numerous Randomized Controlled Trials (RCTs) and systematic reviews focusing on the topical form. These studies monitored outcomes related to symptom resolution and microbiological cure. Research explored whether Phenicol was associated with symptom changes compared to a placebo. The findings are generally consistent across trials, describing patterns observed in the collected data, though the condition's self-limiting nature is a known research limitation.


Evidence Gaps and Areas of Uncertainty

The evidence for Rickettsial diseases relies predominantly on older clinical trials and observational data, lacking modern comparative evidence. Overall research highlights that long-term effects are not fully established for many uses. Studies have explored use in both children and adults; however, results apply only to the specific populations studied. Comparative evidence is lacking in many areas, and the reliance on historical data for systemic uses is a key limitation documented by researchers and regulators.

Key Studies & References

  1. Topical antibiotics for acute bacterial conjunctivitis: Cochrane systematic review and meta-analysis update
  2. Chloramphenicol - eEML - Electronic Essential Medicines List (Used for regulatory/guideline context)
  3. Rocky Mountain spotted fever and other rickettsial infections - Clinical Gate (Used for Rickettsial context)

Frequently Asked Questions (FAQ)

Common questions about Phenicol (FAQ)


Q: How quickly can someone generally expect Phenicol to start working?

A: Official information indicates that Phenicol (Chloramphenicol) is rapidly absorbed into the bloodstream after being taken by mouth. The overall time it takes for a person to notice a reduction in symptoms, such as the clearing of a fever, can vary widely. Symptom improvement depends heavily on the specific type of infection being addressed and its overall severity.


Q: How long does the effect of a Phenicol dose typically last?

A: According to official prescribing information, the 'half-life' of Phenicol—the time it takes for the drug concentration in the body to be reduced by half—is generally short, typically ranging from 1.5 to 4 hours in adults. This rapid clearance rate is the reason systemic Phenicol is administered frequently, often in four divided doses spaced six hours apart.


Q: Are the side effects of Phenicol generally considered temporary or permanent?

A: Side effects of Phenicol can be one of two types. Some effects, like the dose-related suppression of the bone marrow, are often predictable, common, and generally reversible once the medication is stopped. Other adverse effects, particularly the rare condition known as aplastic anemia, are idiosyncratic, not dose-related, and can be permanent or fatal, sometimes appearing weeks or months after treatment ends.


Q: Is it common to feel [Vague side effect, e.g., tired or dizzy] when taking Phenicol?

A: Official patient information mentions that effects such as fatigue, weakness, and dizziness can occur. These feelings are sometimes associated with neurological effects or decreased red blood cell counts (anemia), which can be a side effect of Phenicol. Patients are advised to discuss any new or worsening symptoms with a healthcare professional.


Q: Can Phenicol affect a person's sleep patterns?

A: While specific sleep disturbances are not universally listed, official drug registers do report neurological effects for Phenicol, including mental confusion and mild depression in some patients. These central nervous system effects are documented and can potentially influence a person's sleep habits.


Q: What kind of interactions are listed for Phenicol and alcohol?

A: Some regulatory documents suggest that Phenicol (Chloramphenicol) has the potential to cause minor disulfiram-type reactions. Consultation with a healthcare provider is recommended for information regarding alcohol use during treatment.


Q: Can older adults use Phenicol?

A: Yes, Phenicol can be used by older adults. However, health authorities caution that older individuals may be more susceptible to certain side effects, such as vision changes or an increased risk of confusion. In these cases, close monitoring and possibly dose adjustments are typically required during therapy.


Q: Is Phenicol appropriate for use by children?

A: Phenicol is used to treat serious infections in children, but its use is associated with strict precautions. Use is severely restricted in newborns and premature infants due to the risk of Gray Syndrome. Use in this population often necessitates rigorous blood level monitoring, as described in official labeling. Outside of the infant and neonatal period, the dosage is calculated based on the child's weight.


Q: What considerations exist for women who are pregnant or breastfeeding regarding Phenicol?

A: Official guidance generally does not recommend the use of Phenicol during the last stage of pregnancy or while breastfeeding. This is due to the documented risk of toxicity, including Gray Syndrome, in the newborn. The medication is considered only in situations where the clinical benefit to the patient is believed to strongly outweigh the potential risks to the infant.


Q: Can people with kidney or liver conditions use Phenicol?

A: Yes, individuals with impaired liver or kidney function may be able to use Phenicol, but only under conditions of heightened caution. These conditions require mandatory dose adjustments and close medical supervision because the body’s ability to process and clear the drug may be reduced, increasing the risk of accumulation and toxicity.


Q: Is a prescription always required to get Phenicol?

A: For systemic use (taken orally or by injection), a prescription is always required due to the potential for serious adverse effects. However, in some regions, the topical eye drops or ointments may be classified differently, allowing them to be obtained directly from a pharmacist without a full doctor's prescription for use in adults and older children.


Q: Are there any long-term research studies published about Phenicol?

A: Much of the research evidence for systemic uses of Phenicol relies on clinical trials conducted many years ago. Regulatory bodies acknowledge that data regarding long-term outcomes and the safety profile of the medication are limited and are not fully established for many of its uses.


Q: Where can I find official regulatory information about Phenicol?

A: Official regulatory and prescribing information for Phenicol (Chloramphenicol) is published by governmental health authorities. Patients can find this documentation on government-run websites such as the FDA's DailyMed, the European Medicines Agency (EMA) site, or the drug register maintained by their national health authority.


Q: Why do some people report that Phenicol stopped working for them after a while?

A: Phenicol is an antibiotic used to fight bacterial infections. As with all antibiotics, the targeted bacteria have the potential to develop mechanisms of resistance over time, such as reducing the drug's entry into the cell. If resistance develops, the medication’s ability to stop the bacteria from multiplying can be reduced.


Q: Is it better to take Phenicol in the morning or at night?

A: The primary requirement for systemic administration is maintaining a strict, consistent time interval between doses, typically every six hours. This is crucial for keeping the drug concentration stable in the bloodstream. The specific time of day (morning or night) is considered secondary to maintaining this exact six-hour dosing schedule.


Q: Does Phenicol affect blood pressure or heart rate?

A: General listings of adverse reactions for adult use do not commonly report changes to blood pressure or heart rate. However, a severe cardiovascular event is associated with Gray Syndrome in infants. Regulatory information advises that individuals with pre-existing heart conditions discuss their medical history with their healthcare provider.


Q: Why is Phenicol sometimes described as a last-resort treatment?

A: Phenicol is often reserved for serious, life-threatening infections where other, safer antibiotics are either ineffective or strictly contraindicated. This restriction is enforced primarily because of the drug's rare but well-documented risk of causing a fatal condition called aplastic anemia.


Q: What kind of lab tests might a doctor require before prescribing Phenicol?

A: Due to the risk of blood complications, a doctor may require initial baseline blood tests, such as a Full Blood Count (FBC). Furthermore, official instructions mandate regular blood monitoring during the course of treatment to quickly detect early signs of bone marrow suppression.


Q: Can I drive or operate machinery while using Phenicol?

A: Official product warnings state that Phenicol may cause side effects that can impair judgment, such as mental confusion, dizziness, or blurred vision. The official warnings state that the medication may affect the ability to drive or operate machinery, and caution is recommended until the individual knows how Phenicol affects them.


Q: If I miss a dose of Phenicol, what does the official guidance say I should do?

A: General guidance on missed doses often indicates that the regular dosing schedule should be maintained. The label discourages patients from trying to compensate for a missed dose by taking extra medication.


Q: What happens if I accidentally take two doses of Phenicol close together?

A: Accidental overdosage can lead to gastrointestinal symptoms, including nausea, vomiting, and diarrhea. In case of a suspected overdose, it is important to seek immediate help from a healthcare professional or poison control center.


Q: How does the body generally process and eliminate Phenicol?

A: Phenicol (Chloramphenicol) is primarily processed, or metabolized, by the liver, where it is converted into an inactive metabolite called chloramphenicol glucuronate. The majority of this inactive form of the drug is then cleared from the body by the kidneys and eliminated in the urine.


Q: Is there a generic version of Phenicol available?

A: The active ingredient in Phenicol is Chloramphenicol, which is the official generic name of the drug. Because of this, Chloramphenicol is commonly manufactured and available in various generic formulations from different companies.


Q: Why is it important to complete the full course of Phenicol as directed?

A: Regulatory guidance and consensus among health organizations stress that completing the entire prescribed course is necessary to ensure that all targeted bacteria are fully eradicated. This practice is critical for successful treatment and helps to minimize the risk of the bacteria developing antibiotic resistance.


Q: What are the signs of a serious allergic reaction to Phenicol?

A: Signs of a serious allergic (hypersensitivity) reaction may include severe symptoms such as difficulty breathing or swallowing, swelling of the tongue or throat (angioedema), severe skin rashes, blisters, hives, and fever. The appearance of these symptoms necessitates immediately seeking emergency medical care.


Q: Are there any known issues with Phenicol and dental procedures?

A: Due to the drug’s potential to cause blood-related issues, extra caution is generally required during invasive procedures, including many types of dental work, which carry a risk of bleeding. Official information advises that individuals using this medication disclose this information to their dentist or dental professional before procedures.


Q: Can Phenicol interfere with the effectiveness of birth control?

A: Official drug interaction data suggests that Phenicol (Chloramphenicol) has the potential to affect the levels of certain hormonal contraceptives containing estrogen or progestogen. This interaction may potentially reduce the effectiveness of birth control. It is recommended to discuss the potential need for alternative contraceptive methods with a prescribing physician.


Q: What is the typical half-life of Phenicol in the body?

A: The half-life of Phenicol (Chloramphenicol) is the time it takes for the drug concentration in the body to drop by half. In adults with normal kidney and liver function, this half-life is typically short, generally ranging from 1.5 to 4 hours.


Q: Why is Phenicol not suitable for people with [Vague contraindication, e.g., 'a certain enzyme deficiency']?

A: The official product labeling strictly prohibits the use of Phenicol in patients with acute porphyria, which is a group of metabolic disorders often caused by enzyme deficiencies. Using the medication in these individuals can trigger a severe, life-threatening crisis known as an acute attack.


Q: Is Phenicol known to affect mental clarity or focus?

A: Official prescribing information reports neurotoxic reactions in some patients, including 'headache,' 'mental confusion,' and 'delirium.' These documented effects are the reason why the drug is known to potentially impact a person's mental clarity and ability to focus.


Q: Does Phenicol need to be stored in a special way (e.g., refrigeration)?

A: Storage conditions vary depending on the product form. For example, the powder used for injection should be stored at controlled room temperature (15 C to 30 C). Other specialized forms, such as ophthalmic drops, may require specific instructions, including refrigeration, which will be detailed on the product label.

How should Phenicol be stored and disposed of?

Storage and Disposal Requirements

Official regulations require specific storage conditions for Phenicol (Chloramphenicol) products. All forms must be stored out of the sight and reach of children and kept in a closed container.

Product Form Temperature & Protection Mandates
Oral Capsules/Suspension Store at room temperature, away from heat and moisture. Do not freeze.
Unopened Ophthalmic Requires refrigeration (2 C to 8 C) and protection from light. Do not freeze.

Ophthalmic preparations must be discarded 4 weeks after opening. Unused or expired Phenicol must not be disposed of via wastewater or household waste; instead, ask a pharmacist for the correct disposal method.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Phenicol found in:

A-Z Index: